methazolamide has been researched along with Ankylosing Spondylarthritis in 2 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Excerpt | Relevance | Reference |
---|---|---|
"Methazolamide is a carbonic anhydrase (CA) inhibitor with satisfactory safety." | 1.91 | Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA. ( Gao, P; Liang, W; Liu, Q; Sun, T; Wang, M; Yan, X, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sun, T | 1 |
Wang, M | 1 |
Liang, W | 1 |
Gao, P | 1 |
Liu, Q | 1 |
Yan, X | 2 |
Chang, X | 1 |
Zhang, Y | 1 |
2 other studies available for methazolamide and Ankylosing Spondylarthritis
Article | Year |
---|---|
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA.
Topics: Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Molecular Docking Simulation; Network Pharmaco | 2023 |
Treat ankylosing spondylitis with methazolamide.
Topics: Administration, Oral; Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Spondylitis, Ankylosing | 2011 |